mRNA-2416-P101: A Phase I, Open-Label, Multicenter, Dose Escalation Study of mRNA 2416, a Lipid Nanoparticle Encapsulated mRNA Encoding Human OX40L, for Intratumoral Injection to Patients with Advanced Malignancies

May 09, 2017
https://clinicaltrials.gov/ct2/show/NCT03323398
Solid Tumors
Principal Investigator: Ding Wang, MD
Advanced Solid Tumors
Accepting Participants
(313)916-1784